chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Minor patient- Date of Birth: 06/08/2013 was accompanied to Mall COVID-19 vaccination clinic with childs father and subsequently vaccinated for their 2nd primary series COVID-19 vaccination dose with pediatric Pfizer (5years-11years) Lot# FL0007 in the Left Deltoid on 08/20/2022 at 1920. Per childs vaccinating nurse, LPN in her written report given to this Charge Nurse RN: "Patient injected in LUE, plunger very hard to push and medication squirted out of injection site down patient LUE. RN made aware". This Charge Nurse (Charge RN) RN writing this report was not present during patient vaccination but responded following vaccination incident after being alerted by the vaccinators scribe (no relation to Charge RN). LPN stayed with the patient per protocol while Charge RN was alerted by scribe. This Charge RN responded to the area where child was vaccinated and introduced self to the childs father, and then spoke with the vaccinating nurse. LPN who described that from their clinical observation some, but not all, of the vaccine dose squirted out of the side of the VanishPoint syringe plunger during vaccination. LPN from her clinical observation believed that the minor patient received at least half of the recommended dose. Charge RN then asked the patient's father who was present and observed the vaccination process if he also agreed the child received at least half the recommended dose. Childs father also stated that they believed their child received at least half the recommended dose. The patient left deltoid was visibly assessed by Charge RN, no apparent adventitious finding noted. The VanishPoint Syringe was also visibly assessed by Charge RN, observed by vaccinating nurse LPN, and assessed by clinic pediatric vaccination Point-of-Contact RN. All three nurses agreed following individual assessment or observation that the VanishPoint needle had fully retracted into the syringe, yet all agreed that there was a visible small amount of clear, colorless suspected vaccine fluid left inside the syringe possibly caused by suspected malfunctioning VanishPoint syringe. Charge RN also notified Site Supervisor RN remotely who also stated that if both vaccinating clinician and patient's parent/guardian agree that the child received at least half the recommended COVID-19 vaccination dose then we did not need to re-vaccinate child in opposite arm. Patient father informed by Charge RN and child's father stated he further confirmed he felt comfortable that his child received an adequate dose and did not want to re-vaccinate. Patient father educated by Charge RN, and Charge RN also asked father if they had any further questions. Patient father denied that they had any further questions at that time but informed we will file a report and he may be contacted by the CDC or Public Health. Minor patient safely completed post-vaccination observation in the clinic at around 1940 and safely walked out of the clinic with father.
PATIENT REPORTED RIGHT LEG SWELLING THE EVENING AFTER THE VACCINE. SWELLING SUBSIDED BY THE FOLLOWING MORNING. PATIENT DID NOT SEEK MEDICAL ATTENTION.
Felt dizzy within 30 minutes of injection; Exposure during pregnancy; Pain on injection arm; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of DIZZINESS (Felt dizzy within 30 minutes of injection), EXPOSURE DURING PREGNANCY (Exposure during pregnancy) and INJECTION SITE PAIN (Pain on injection arm) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included Ultrasound fetal (Normal) in December 2020, Non-invasive prenatal testing in December 2020 and Term birth on 13-Jul-2018. Concurrent medical conditions included Drug allergy (Keflex).    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in September 2020 and the estimated date of delivery was 21-Jun-2021. On 16-Mar-2021, the patient experienced DIZZINESS (Felt dizzy within 30 minutes of injection), EXPOSURE DURING PREGNANCY (Exposure during pregnancy) and INJECTION SITE PAIN (Pain on injection arm). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 16-Mar-2021, EXPOSURE DURING PREGNANCY (Exposure during pregnancy) had resolved. At the time of the report, DIZZINESS (Felt dizzy within 30 minutes of injection) and INJECTION SITE PAIN (Pain on injection arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided.  The patient had a positive pregnancy test on 02 Oct 2020. No treatment information provided.
Sedation, Myalgia, Arthralgia, Fever, NauseaVomiting, chills Narrative:
pt recvd vax 11OCT95 & by 12OCT95 pt had devel a rash around the inj site & itching @ both palms, above the lt knee & the rt elbow;the pt has recovered;
12 hours after second dose onset of following symptoms: Low grade fever (99.9) Extreme body aches Headache  Tinnitus Popping sound in ears Light headed / dizziness  Extremely sore right arm Taking ibuprofen 400mg / every 4 hours
1/19/2021- Sore left arm at injection site 1/20/2021- Fever (100.2), aches, chills, strong headache, occasional nausea
stroke like systems including seizure, memory loss.  Transported to emergency room at hospital via ambulance . Following test performed;  cat scan, IGG scan, and MRI with contras .  No exact cause for the seizure was determined at this time.
very irritable @ 5PM; didn't sleep well; next day had temp of 101; did not want to move or picked up; only moves hands; no severe local reactions; seen by MD 11JAN95; had ear infect; advised DTAP next time;
After 10 minutes from receiving a Tdap in my left arm.  My left arm and hand went numb.  Received Tdap at 12:10 pm on 2/1/2008.  Course of treatment recommendations: Call MD asap for advice.  Rest and elevate left arm. Ice and warm packs at 20 minute intervals alternating ice and warm every two hours.  Tylenol over the counter for comfort.  Client denies any chest pain, no shortness of breath noted at time of interview.  Let Medical MD know of recommendations and stop treatment if MD indicates to.  2/4/2008-Left message for patient to call.  Returned call 10 minutes later.  Stated that arm was numb until 8:30 pm on 2/1/2008.  Arm gradually recovered over time.  Did not do recommended treatment.  Stated arm is better now.
Had shingles three times had shots\ Suspected vaccination failure; Shingles three times, each is worse; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had Shingles shots and had shingles three times each time was worse. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
swollen neck lymph nodes; sore arm; This case was reported by a consumer via call center representative and described the occurrence of lymphadenopathy cervical in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included drug allergy.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced lymphadenopathy cervical and pain in arm. On an unknown date, the outcome of the lymphadenopathy cervical and pain in arm were recovered/resolved.   It was unknown if the reporter considered the lymphadenopathy cervical and pain in arm to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient stated that it had almost been 2 months since she received dose 1 of Shingrix.  She stated that after she received dose 1 of the vaccine she experienced swollen neck lymph nodes and a sore arm. It took a few days but these symptoms were resolved. The reporter did not consent to follow-up.
COUGHING ALL DAY WITH DRY COUGH; FEELING DIZZY; FATIGUE; FEVER; NAUSEAOUS; SHARP PAIN IN THE UPPER RIGHT SHOULDER NEAR INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 64 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19, and gall bladder taken out, and concurrent conditions included long covid hauler.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 02-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 02-JUN-2021, the subject experienced sharp pain in the upper right shoulder near injection site pain. On 03-JUN-2021, the subject experienced coughing all day with dry cough. On 03-JUN-2021, the subject experienced feeling dizzy. On 03-JUN-2021, the subject experienced fatigue. On 03-JUN-2021, the subject experienced fever. On 03-JUN-2021, the subject experienced nauseaous. Laboratory data included: Body temperature (NR: not provided) 101 F. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, was recovering from coughing all day with dry cough, and had not recovered from fatigue, nauseaous, feeling dizzy, and sharp pain in the upper right shoulder near injection site pain. This report was non-serious.
Sudden LOC, possible seizure (rigidity) for 5 sec, no post-ictal state, but some disorientation. 99 on RA,118/76, 99-103 HR, tachypnea to 26. Assessed by EMS, pt refused transport- paramedic got AMA signed.  Vasovagal response, Confusion, Disorientation, Loss of consciousness
Body aches; Chest hurts when they cough; Coughing up a bloody phelgm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), CHEST PAIN (Chest hurts when they cough) and HAEMOPTYSIS (Coughing up a bloody phelgm) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced PAIN (Body aches), CHEST PAIN (Chest hurts when they cough) and HAEMOPTYSIS (Coughing up a bloody phelgm). At the time of the report, PAIN (Body aches), CHEST PAIN (Chest hurts when they cough) and HAEMOPTYSIS (Coughing up a bloody phelgm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Patient recieved 0.1ml of Pfizer covid vaccine us correct dose of 0.3mL IM. No adverse effects noted.
20 cm red, swollen from above elbow to upper forearm right arm. Motrin 800 mg and Allegra 60 mg prescribed. Recommended premedicate before annual booster.
Red spots on her arm that spread and went underneath and towards her chest. Benadryl was recommended along with tylenol.
Lt thigh devel local redness, & knot about 2cm & tenderness-warmth; no fever; Pt seen by MD on 16MAR92;
approx 30-35hr p/vax sore throat, gen malaise, diff sleeping then 16hr later called pharm;inc severity of sore throat, pressure h/a;nuchal rigidity, SOB, constriction around entire chest;anxiety, fever;weak, facial sinus tender;
Pt received the PNEUMOVAX 23 around 3pm and around 2 hours later her arm began hurting very bad. Her pain was under her arm as well. Redness and puffiness was also an issue.
Pfizer-BioNTech COVID-10 Vaccine EUA.  Patient came to vaccine clinic. Patient told vaccinator that she has a history of passing out with needles. Vaccinator administered the vaccine, patient was doing well and moved to the monitoring area. Patient was sitting in a chair for 15 minute observation period. She began to have soreness to arm about 5 minutes after sitting down then began to feel lightheaded and immediately had syncopal episode. Staff was present and reported legs shaking and loss of bladder during episode. Patient was lowered to the ground and Rapid Response was contacted. Patient was taken to KU ED.
Rash started on arm, itchy spread to trunk, legs and back more each day over 4 days.
rash has appeared to become redder and bigger; rash at the injection site / rash has appeared to become / bigger; This case was reported by a consumer via call center representative and described the occurrence of injection site rash in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd September 2020, the patient received the 1st dose of Shingrix (intramuscular). In September 2020, less than a week after receiving Shingrix, the patient experienced injection site rash and injection site erythema. The patient was treated with cortisone (non-proprietary) (Cortisone Cream) and benadryl (nos) (Benadryl). On an unknown date, the outcome of the injection site rash and injection site erythema were unknown.   It was unknown if the reporter considered the injection site rash and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left arm.  After receiving Shingrix, the patient developed a rash at the injection site.  The rash had appeared to become redder and bigger.  The patient's pharmacist recommended ice, Cortisone cream and Benadryl.  The patient planned to consult her physician regarding the rash. The reporter consented to follow up.  All information was not available.
Patient reported that she had pain and soreness to the left arm that evening of rcvding her 1st dose on 3/17/2021. On the next day, the left arm was sore to the touch. The pain and soreness went away on the 3rd day.  Patient also reported that approx. on Wed (3/31/2021) or Thur (4/1/2021) she noticed her left arm have a patchy red appearance and it was itchy. She also stated that 4/3/2021 that area got really red, and it is still red this morning with her skin on the upper left arm area appears to be swollen/puffy.  Patient reported she cleaned her upper left arm area with witch hazel and applied cortisone cream in the morning and evening. This helped with the itchiness, but not with the redness.  Recommend patient to keep her eyes on that area, and if her symptoms is getting worse or not better to call her health care provider, urgent care or emergency room per based on what she report she may be asked to seek medical care. Also recommend that she can take Benadryl if needed before bed to lessen the feeling of drowsiness, and for any pain or soreness she can take Tylenol. Also advised that based on the reactions she described, this is not a contraindication from getting the 2nd dose which she is scheduled for on 4/16/2021. If she is concerned about rcvding the 2nd dose recommend that she contact her PCP to discuss further.   Please follow up with patient after 2pm 4/5/2021 per she stated she will contact her PCP tomorrow.
The patient inadvertently received a dose of 0.51 to 0.52 mL as opposed to 0.5 mL. The manufacturer instructed us to reach out to the patient to let them know that there is a potential for increased adverse events locally and/or systemically. The patient reported a sore arm but no serious adverse reactions were experienced.
I have feeling dizzy since the shot. It is hard to keep my balance and I feel foggy most of the day.
vaccine leaked out; This spontaneous case was reported by a health care professional and describes the occurrence of UNDERDOSE (vaccine leaked out) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced UNDERDOSE (vaccine leaked out). On 31-Mar-2021, UNDERDOSE (vaccine leaked out) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to the events were not applicable.
Systemic: anxiety-Medium, Additional Details: pt passed out from shot for couple seconds and mom confirmed he got same reaction after meningitis shot he was breathing paramedic confirmed it was just anxiety and dehydration . all vitals were normal and pt went home with mom who came for shot with him
After being given an overdose of vaccines my daughter has had the following symptoms: paleness, fever, vomiting, loss of appetite, crankiness, sleeplessness, pain that is inconsolable and sinus congestion.
rash; hives/Hives on her upper legs, buttocks, and stomach; Her ears were purple and inflamed; itchy; sore arm; headache; This is a spontaneous report received from a Contactable consumer. A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EK5730 and Expiration date was not reported), via an unspecified route of administration, in Arm left, on 30Dec2020, Wednesday (at the age of 53 years), as a single dose for COVID-19 immunization. The patient medical history included Blood pressure and Cholesterol. Concomitant medications included Losartan with Hydrochlorothiazide for Blood pressure, Crestor for cholesterol. There was no patient history and no Investigation Assessment. On an unknown date, the patient stated that she had a delayed reaction. Three to four days later, she developed a rash and hives. That night, on the vaccination day she developed headache and a sore arm on 30Dec2020. She doesn't know if it was related or not, but on 02Jan2021, she became itchy. On 03Jan2021, she had hives on her upper legs, buttocks, and stomach. On 03Jan2021, her ears were purple and inflamed. She was supposed to get the second shot, but she was not sure if she should or shouldn't get it. She was scheduled three weeks after her first, but didn't go because she was afraid. She works at a nursing home, and now some of the residents are getting their first shot so she has the option to get her second today. Her headache started during her sleep. She just took Advil for the headache. She still has little headaches on and off so she is unsure if they are related. It took about 3 days for the arm soreness to go away. She went to urgent care, and they gave her prednisone for 5 days. It was Friday the 8Jan2021 when she stopped itching and having hives. She didn't really want to get the vaccine in the first place but did because she works in healthcare. Outcome of the event rash was reported as unknown and headache, itchy, hives, sore arm, ear infection was reported as recovered.  Follow-up attempts completed. No further information expected.
Administered vaccine on 3-17, on 3-29 developed varicella like rash that remained on head, face, arms, neck, torso only. No itching or itchiness at all, no pain at all. Rash persisted despite administration of Benadryl. Developed fever after rash on day 2 of 102. Fever on day three became 103 despite treatment with Motrin and Tylenol. Day 4 he had 105.5 fever again despite treatment with medications. Near no medical facilities, we put him in an ice bath to bring down his fever that would not stop going up. We finally got him to level off at 102.5 for day 5, 6, and 7 with non-stop medications in him. Day 8, 9, 10 fever dropped to 101 and by day 12 was done. Day 14 blister are crusted and healing. Patient has already had chicken pox. We entertained the possibility of a reocurrence however no one he has been to school with or played with has a current or recent outbreak. He has had reactions to DTP and DTap as well.  4/15/08 Reviewed vax record which provides lot # for Hep A as GSK AHAVB216AA.  Office vs of 4/10/08 for rash all over body x 2 weeks, fatigue & fever. No vesicles, now scabbed over.   FINAL DX: varicella post vaccination.
Starting 1/23/21 - pain and swelling in armpit that has continued (including today) - very itchy  on 1/24 and became swollen again  at injection site (1+ week after shot)
Rash, erythema, heat and induration at vaccination site 8 days after vaccine Narrative: treated with IM rocephin and oral antibiotics x 10 days
My "man boobs" have been sore since May! Had mammogram, looked o.k., some lumps.
Mom called office 4/16/09 0900 to report a baseball sized, red, itchy but not raised area at left upper arm at injection site; no respiratory involvement, no fever, happy and playful, administering BENADRYL prn
Information has been received from an approx 40 yr old female physician who on 24Oct05 was vaccinated SC with a 0.5ml, second dose of hep A virus vaccine inactivated (lot646790/0693N). Concomitant therapy included influenza virus vaccine (unspecified) and tuberculin purified protein derivative. On 24Oct05 the pt developed blood red eyes, swollen eyes, itchy eyes, swollen tongue and cough approx 1-2 hrs after the dose. She was treated with diphenhydramine hydrochloride (Benadryl) after which a fever developed. As of 28Oct05, she had recovered from the events. Additional information has been requested.
general fuzzy mental condition, some confusion, inability to concentrate, dizzy for about two-minutes after physical labor (cleaning garage)
Mouth felt like it was on fire, fatigue, throat was sore, migraine. It was allergies.. Relocated in Apfil. They gave me a shot in my arm for the pain, just said not to take anything OTC for 24 hours because the shot was like a 'little bit of everything'. Also gave me a steroid pack and antibiotics. I was worried about having COVID again or a virus or something. So, they gave me all of that just to be safe. I started taking Zyrtec, got a humidifier and took Mucinex for about 10 days and was good to go, it was definitely allergies.
Two days post vax, the pt developed an injection site reaction characterized by a severe hive, itching, and pain which lasted 3 days. The pt then developed a bruise which lasted several days. The pt recovered. This is one of eight pts from this facility who had an adverse experience following receipt of vax.
crying, irritable, no fever, no URI sx. The pt was taken to another MD, he told me via phone that pt worked up. No infection found & pt was doing well upon D/C. Crying started 12Feb. Reporter 1st notified 13Feb & made referral.
In office seizure. Patient had seizure while Mom was carrying him at the check out window. Seizure happened six minutes after vaccination and instead about five seconds. The patient was examined by the doctor and received oxygen for 15 minutes for comfort, Pt was tired but back to baseline. Oxygen 93%. Pt temp after seizure 97.4.